Media coverage
35
Media coverage
Title Epizyme’s Tazverik receives accelerated approval from FDA Media name/outlet Pharmaceutical Technology Country/Territory United States Date 24/01/20 URL https://www.pharmaceutical-technology.com/news/epizyme-taxverik-fda-approval/ Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Nasdaq Country/Territory United States Date 24/01/20 URL https://www.nasdaq.com/press-release/epizyme-announces-u.s.-fda-accelerated-approval-of-tazveriktm-tazemetostat-for-the Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet PipelineReview Country/Territory Spain Date 24/01/20 URL https://pipelinereview.com/index.php/2020012473610/Small-Molecules/Epizyme-Announces-U.S.-FDA-Accelerated-Approval-of-TAZVERIK-tazemetostat-for-the-Treatment-of-Patients-with-Epithelioid-Sarcoma.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet BioSpace Country/Territory United States Date 24/01/20 URL https://www.biospace.com/article/releases/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma/?s=95 Persons Gary Schwartz Title EPIZYME : Announces U.S. FDA Accelerated Approval of TAZVERIK for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet MarketScreener.com Country/Territory United States Date 24/01/20 URL https://www.marketscreener.com/EPIZYME-INC-13314771/news/Epizyme-Announces-U-S-FDA-Accelerated-Approval-of-TAZVERIK-for-the-Treatment-of-Patients-with-Epi-29885731/ Persons Gary Schwartz Title About Epithelioid Sarcoma Media name/outlet TheStreet.com Country/Territory United States Date 23/01/20 URL https://www.thestreet.com/press-releases/about-epithelioid-sarcoma-15217771 Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Morningstar.com Country/Territory United States Date 23/01/20 URL https://www.morningstar.com/news/business-wire/20200123005858/epizyme-announces-us-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Global Banking & Finance Review Country/Territory United Kingdom Date 23/01/20 URL https://www.globalbankingandfinance.com/category/news/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma/ Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Maryville Daily Times Country/Territory United States Date 23/01/20 URL https://www.thedailytimes.com/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_e542dcfa-4e15-5d12-a10e-21a400923c26.html Persons Gary Schwartz Title EPIZYME : Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet MarketScreener.com Country/Territory United States Date 23/01/20 URL https://www.marketscreener.com/EPIZYME-INC-13314771/news/Epizyme-Announces-U-S-FDA-Accelerated-Approval-of-TAZVERIK-trade-tazemetostat-for-the-Treatmen-29883241/ Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK ™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Stockwatch Country/Territory Canada Date 23/01/20 URL www.stockwatch.com/News/Item?bid=U-b20200123005858-U%3aEPZM-20200123&symbol=EPZM®ion=U Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Market Newsdesk Country/Territory United States Date 23/01/20 URL www.marketnewsdesk.com/?p=201412 Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Wallstreet Online Country/Territory Germany Date 23/01/20 URL https://www.wallstreet-online.de/nachricht/12094110-epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Crwe World Country/Territory United States Date 23/01/20 URL crweworld.com/article/news-provided-by-business-wire/1390718/epizyme-announces-us-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Spoke.com Country/Territory United States Date 23/01/20 URL www.spoke.com/press_releases/5e2a1fad343327130601df0d Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Jotup Country/Territory United States Date 23/01/20 URL https://jotup.co/node/633928 Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Acrofan Date 23/01/20 URL https://us.acrofan.com/detail.php?number=226838 Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK(TM) (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma; First and Only EZH2 Inhibitor Approved by the U.S. Food and Drug Administration; U.S. Commercial Launch Underway; Compan Media name/outlet Business Wire Country/Territory United States Date 23/01/20 Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet CIT Country/Territory United States Date 23/01/20 URL www.businesswire.com/news/home/20200123005858/en/Epizyme-Announces-U.S.-FDA-Accelerated-Approval-TAZVERIK%E2%84%A2/ Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet The Argus-Press Country/Territory United States Date 23/01/20 URL https://www.argus-press.com/news/national/article_4ecc8548-296c-5c10-ba47-13bb899e905b.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Maryville Daily Forum Country/Territory United States Date 23/01/20 URL www.maryvilleforum.com/news/state_news/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_3191deff-709d-58eb-a42d-7bbe8c5e970b.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Ludington Daily News Country/Territory United States Date 23/01/20 URL www.shorelinemedia.net/ludington_daily_news/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_b2573927-829a-5283-824d-275a6d668df8.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Manchester Times Country/Territory United States Date 23/01/20 URL https://www.manchestertimes.com/news/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_6c4495d2-08d9-52e4-b141-af9f9582cf27.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Valdosta Daily Times Country/Territory Georgia Date 23/01/20 URL https://www.valdostadailytimes.com/news/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_6df53728-987a-5cc2-8878-d3c6098bd701.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Herald Chronicle Country/Territory United States Date 23/01/20 URL https://www.heraldchronicle.com/news/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_f072ac5b-8cb7-587e-916e-68303975963c.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Elk Valley Times Country/Territory United States Date 23/01/20 URL https://www.elkvalleytimes.com/news/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_1179c828-acb8-56a7-ad69-acb7763a451b.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet KULR 8 Country/Territory United States Date 23/01/20 URL https://www.kulr8.com/news/money/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_b298f6f9-a098-5b8a-abe0-296a22877f36.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Citizen Tribune Country/Territory United States Date 23/01/20 URL https://www.citizentribune.com/news/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_a972d718-19f5-584a-b934-95ce90c0c964.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Tullahoma News Country/Territory United States Date 23/01/20 URL https://www.tullahomanews.com/news/business/epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat/article_23287f07-e21b-5f31-a516-f174add0d85a.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Galveston County Daily News Country/Territory United States Date 23/01/20 URL https://www.galvnews.com/news_ap/business/article_e95c9bab-53c5-5956-819f-9cde724a8f2c.html Persons Gary Schwartz Title Epizyme Inc: Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma (Businesswire) Media name/outlet Avanza Bank AB Country/Territory Sweden Date 23/01/20 URL https://www.avanza.se/placera/pressmeddelanden/2020/01/23/epizyme-inc-epizyme-announces-u-s-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma.html Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Erie News Now Country/Territory United States Date 23/01/20 URL www.erienewsnow.com/story/41604791/epizyme-announces-us-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet FOX21 Delmarva Country/Territory United States Date 23/01/20 URL www.fox21delmarva.com/story/41604791/epizyme-announces-us-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK™ (tazemetostat) for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet Tulsa CW Country/Territory United States Date 23/01/20 URL www.tulsacw.com/story/41604791/epizyme-announces-us-fda-accelerated-approval-of-tazverik-tazemetostat-for-the-treatment-of-patients-with-epithelioid-sarcoma Persons Gary Schwartz Title Epizyme Announces U.S. FDA Accelerated Approval of TAZVERIK tazemetostat for the Treatment of Patients with Epithelioid Sarcoma Media name/outlet BioPortfolio Country/Territory United Kingdom Date 23/01/20 URL https://www.bioportfolio.com/news/article/4200584/Epizyme-Announces-U-S-FDA-Accelerated-Approval-of-TAZVERIK-tazemetostat-for-the.html Persons Gary Schwartz